Key Events This Week
22 Jun: Valuation metrics upgraded to attractive, signalling renewed price appeal
25 Jun: Sharp 21.9% surge in open interest amid mixed market signals
25 Jun: Technical momentum shifts from mildly bearish to sideways trend
26 Jun: Week closes at Rs.5,421.65 (+0.87%) outperforming Sensex
22 June: Valuation Metrics Signal Renewed Price Attractiveness
On 22 June, Alkem Laboratories’ stock price closed at Rs.5,366.40, down marginally by 0.16% from the previous close of Rs.5,374.75. Despite this slight dip, the company’s valuation parameters improved notably, with its price-to-earnings (P/E) ratio at 26.53 and price-to-book value (P/BV) at 4.64, positioning the stock as attractively priced relative to its historical averages and peer group.
The enterprise value to EBITDA (EV/EBITDA) ratio of 21.18 further supported this view, especially when compared to more expensive peers such as Laurus Labs and Mankind Pharma. Alkem’s return on capital employed (ROCE) and return on equity (ROE) stood at robust levels of 19.58% and 17.48% respectively, underscoring efficient capital utilisation and profitability.
However, the overall Mojo Grade was downgraded to Sell on 11 May 2026, reflecting caution amid valuation shifts and sector headwinds. This mixed fundamental backdrop set the tone for a week of measured price movements.
Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!
- - Latest weekly selection
- - Target price delivered
- - Large Cap special pick
23 June: Stock Gains Despite Sensex Decline
On 23 June, Alkem Laboratories rebounded strongly, closing at Rs.5,411.25, up 0.84% on the day, while the Sensex declined by 1.05% to 35,959.97. This divergence highlighted the stock’s relative strength amid broader market weakness. The surge in volume to 77,494 shares indicated renewed investor interest, likely driven by the improved valuation narrative established the previous day.
24 June: Continued Gains with Low Volume
The stock extended gains on 24 June, closing at Rs.5,431.05, a 0.37% increase, albeit on thin volume of just 1,300 shares. The Sensex recovered 0.53% to 36,151.68, but Alkem’s modest advance suggested cautious optimism. Delivery volumes rose by 12.23% compared to the five-day average, signalling accumulation by longer-term investors despite subdued trading activity.
25 June: Sharp Open Interest Surge Amid Mixed Technical Signals
On 25 June, Alkem Laboratories experienced a notable 21.9% increase in open interest in its derivatives segment, rising from 20,394 to 24,861 contracts. This surge reflected heightened market activity and speculative positioning, with a total derivatives notional value exceeding ₹59,000 lakhs. Despite this, the stock price dipped slightly by 0.17% to Rs.5,421.65, indicating a lack of decisive directional movement.
Technically, the stock’s momentum shifted from mildly bearish to a sideways trend. Key indicators such as the weekly MACD remained bearish, while monthly MACD and Bollinger Bands suggested mild bullish potential. The Relative Strength Index (RSI) hovered neutrally, and volume-based On-Balance Volume (OBV) showed mild accumulation. This mixed technical picture underscored market indecision amid sector headwinds.
Alkem Laboratories Ltd or something better? Our SwitchER feature analyzes this mid-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Weekly Price Performance: Alkem Laboratories vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-22 | Rs.5,366.40 | -0.16% | 36,342.26 | +0.46% |
| 2026-06-23 | Rs.5,411.25 | +0.84% | 35,959.97 | -1.05% |
| 2026-06-24 | Rs.5,431.05 | +0.37% | 36,151.68 | +0.53% |
| 2026-06-25 | Rs.5,421.65 | -0.17% | 36,133.32 | -0.05% |
Key Takeaways
Valuation Improvement: The upgrade in valuation metrics to an attractive rating despite a Sell grade indicates that Alkem Laboratories is trading at a more reasonable price relative to earnings and sector peers. This provides a cushion for investors amid sector volatility.
Derivatives Market Activity: The sharp 21.9% rise in open interest on 25 June signals increased speculative interest and potential for a directional move. However, the lack of a strong price breakout suggests market indecision and the need for cautious monitoring.
Technical Momentum Shift: The transition from mildly bearish to sideways technical momentum reflects a consolidation phase. Mixed signals from MACD, RSI, Bollinger Bands, and volume indicators highlight uncertainty but also mild bullish potential if accumulation continues.
Relative Outperformance: Alkem outperformed the Sensex over the week (+0.87% vs -0.11%), demonstrating resilience in a cautious market environment. Long-term returns remain strong, reinforcing the company’s fundamental strength despite short-term technical caution.
Conclusion
Alkem Laboratories Ltd’s week was characterised by a blend of improved valuation appeal, heightened derivatives activity, and a nuanced technical momentum shift. While the stock managed to outperform the Sensex modestly, the overall market sentiment remains cautious, reflected in the Sell Mojo Grade and mixed technical indicators.
Investors should consider the attractive valuation metrics alongside the increased open interest and sideways price action as signals of potential upcoming volatility. The stock’s long-term outperformance and solid returns on capital provide a strong fundamental base, but the current technical consolidation advises prudence.
Monitoring key support near Rs.5,420 and resistance around Rs.5,488, alongside sector developments and derivatives positioning, will be essential to gauge the stock’s next directional move. Until clearer signals emerge, a balanced approach remains warranted in this mid-cap pharmaceutical stock.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
